This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Modeling synaptic vesicles: how does alpha-Synuclein inhibit fusion? Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Biology of Native Alpha-Synuclein Tetramers in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models Investments > €500k United States of America Motor neurone diseases 2016
NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntingtons Disease Investments > €500k United States of America Huntington’s disease 2016
Misfolded ALS-linked Profilin-1: a novel therapeutic target Investments > €500k United States of America Motor neurone diseases 2016
Lewy body neuropathologies and SNCA gene: variants expression and splicing Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Neuroprotective Immunity and HIV Dementia Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Functions of Metabotropic Glutamate Receptor Subtypes Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy Investments > €500k United States of America Spinal muscular atrophy (SMA) 2016
Molecular phenotyping of cortical cell types in multiple rodent models of ALS Investments > €500k United States of America Motor neurone diseases 2016
